Effectiveness of 17DMAG, a Geldanamycin Derivative, in Murine Acute Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|121|1|32-36

ISSN： 0001-5792

Source： Acta Haematologica, Vol.121, Iss.1, 2009-03, pp. : 32-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunotherapy in acute myeloid leukemia

By  

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Epidermal Growth Factor Receptor by an Experimental Murine Tumor of Acute Myeloid Leukemia Origin

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-11 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis

By  

Acta Haematologica, Vol. 133, Iss. 3, 2014-12 ,pp. : 300-309

Karger

Access to resources Recommend Favorite

17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition

By                

International Journal of Molecular Medicine, Vol. 36, Iss. 2, 2015-01 ,pp. : 424-432

Spandidos Publications

Access to resources Recommend Favorite

The denominator variable in the quantitation of MRD in acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : E213-E215

John Wiley & Sons Inc

Access to resources Recommend Favorite